[Edaily Reporter Shin Ha-yeon ] JETEMA Co.,Ltd.(216080)announced on the 15th that it has signed an exclusive supply contract for pharmaceuticals and medical devices worth a total of 40.23 billion won with a domestic distributor.
First, the confirmed contract amount for the exclusive supply of the pharmaceutical product “Toxin” is 30.15 billion won, which accounts for 39.66% of recent sales.
Separately, the company also signed an exclusive supply contract for fillers, a medical device. The confirmed contract amount is 10.08 billion won, representing 13.1% of recent sales.
The term of both contracts runs from the 14th to October 14, 2031. The identity of the contracting party will not be disclosed until the end of the contract period to protect business confidentiality.
First, the confirmed contract amount for the exclusive supply of the pharmaceutical product “Toxin” is 30.15 billion won, which accounts for 39.66% of recent sales.
Separately, the company also signed an exclusive supply contract for fillers, a medical device. The confirmed contract amount is 10.08 billion won, representing 13.1% of recent sales.
The term of both contracts runs from the 14th to October 14, 2031. The identity of the contracting party will not be disclosed until the end of the contract period to protect business confidentiality.
